Argon plasma coagulation, bipolar cautery, and cryotherapy: ABC's of ablative techniques

A variety of endoscopic ablation modalities are available for the treatment of Barrett’s esophagus. Multiple studies have evaluated the use of argon plasma coagulation, mostly in nondysplastic Barrett’s esophagus. Significant variations in technique, end points, and follow-up exist between studies, but in most cases argon plasma coagulation is associated with unacceptable rates of persistent intestinal metaplasia and recurrence after completion of treatment. In addition, serious adverse events including perforation and stricture formation are reported. Multipolar electrocoagulation has been studied less thoroughly, but in prospective trials significant rates of persistent and recurrent intestinal metaplasia have also been reported. Lasers and heater probes have been tried in small numbers. Endoscopic cryotherapy ablation is a relatively new technique with studies focusing on high-grade dysplasia and early-stage cancer in high-risk patients. It has an acceptable safety profile, and early results show response in a significant number of patients in whom other modalities have failed.

References

• 1 Berenson M M, Johnson T D, Markowitz N R. et al . Restoration of squamous mucosa after ablation of Barrett’s esophageal epithelium.  Gastroenterology. 1993;  104 1686-1691
• 2 Manner H. Argon plasma coagulation therapy.  Curr Opin Gastroenterol. 2008;  24 612-616
• 3 Bright T, Watson D I, Tam W. et al . Randomized trial of argon plasma coagulation versus endoscopic surveillance for Barrett’s esophagus after antireflux surgery: late results.  Ann Surg. 2007;  246 1016-1020
• 4 Dulai G S, Jensen D M, Cortina G, Fontana L. Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett’s esophagus.  Gastrointest Endosc. 2005;  61 232-240
• 5 Ferraris R, Fracchia M, Foti M. et al . Barrett’s oesophagus: long-term follow-up after complete ablation with argon plasma coagulation and the factors that determine its recurrence.  Aliment Pharmacol Ther. 2007;  25 835-840
• 6 Madisch A, Miehlke S, Bayerdorffer E. et al . Long-term follow-up after complete ablation of Barrett’s esophagus with argon plasma coagulation.  World J Gastroenterol. 2005;  11 1182-1116
• 7 Manner H, May A, Miehlke S. et al . Ablation of nonneoplastic Barrett’s mucosa using argon plasma coagulation with concomitant esomeprazole therapy (APBANEX): a prospective multicenter evaluation.  Am J Gastroenterol. 2006;  101 1762-1769
• 8 Mörk H, Al-Taie O, Berlin F, Kraus M R, Scheurlen M. High recurrence rate of Barrett’s epithelium during long-term follow-up after argon plasma coagulation.  Scand J Gastroenterol. 2007;  42 23-27
• 9 Schulz H, Miehlke S, Antos D. et al . Ablation of Barrett’s epithelium by endoscopic argon plasma coagulation in combination with high dose omeprazole.  Gastrointest Endosc. 2000;  51 659-663
• 10 Sharma P, Wani S, Weston A P. et al . A randomised controlled trial of ablation of Barrett’s oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term results.  Gut. 2006;  55 1233-1239
• 11 Van Laethem J L, Cremer M, Peny M O. et al . Eradication of Barrett’s mucosa with argon plasma coagulation and acid suppression: immediate and mid term results.  Gut. 1998;  43 747-751
• 12 Attwood S E, Lewis C J, Caplin S. et al . Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett’s esophagus.  Clin Gastroenterol Hepatol. 2003;  1 258-263
• 13 Pereira-Lima J C, Busnello J V, Saul C. et al . High power setting argon plasma coagulation for the eradication of Barrett’s esophagus.  Am J Gastroenterol. 2000;  95 1661-1668
• 14 Ragunath K, Krasner N, Raman V S. et al . Endoscopic ablation of dysplastic Barrett’s oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost-effectiveness.  Scand J Gastroenterol. 2005;  40 750-758
• 15 Kovacs B, Chen Y, Lewis T S. et al . Successful reversal of Barrett’s esophagus with multipolar electrocoagulation despite inadequate acid suppression.  Gastrointest Endosc. 1999;  9 547-553
• 16 Montes C, Brandalise N, Deliza R. et al . Antireflux surgery followed by bipolar electrocoagulation in the treatment of Barrett’s esophagus.  Gastrointest Endosc. 1999;  50 173-177
• 17 Sampliner R E, Fennerty B, Garewal H S. Reversal of Barrett’s esophagus with acid suppression and multipolar electrocoagulation: preliminary results.  Gastrointest Endosc. 1996;  44 532-535
• 18 Sharma P, Bhattacharyya A, Garewal H S, Sampliner R E. Durability of new squamous epithelium following endoscopic reversal of Barrett’s esophagus.  Gastrointest Endosc. 1999;  50 159-164
• 19 Sampliner R E, Faigel D, Fennerty B. et al . Effective and safe endoscopic reversal of nondysplastic Barrett’s esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study.  Gastrointest Endosc. 2001;  53 554-558
• 20 Arnott J. Practical illustrations of the remedial efficacy of a very low or anaesthetic temperature.  Lancet. 1850;  2 257-259
• 21 Allington H V. Liquid nitrogen in the treatment of skin diseases.  Calif Med. 1950;  72 153-155
• 22 Cooper I, Lee A. Cryostatic congelation: a system for producing a limited controlled region of cooling or freezing of biological tissue.  J Nerv Ment Dis. 1961;  133 259-263
• 23 Pasricha P J, Hill S, Wadwa K S. et al . Endoscopic cryotherapy: experimental results and first clinical use.  Gastrointest Endosc. 1999;  49 627-631
• 24 Kalloo A. Colon – cryotherapy for radiation proctitis. The DAVE Project 2006 Available from: http://daveproject.org/viewfilms.cfm?film_id = 378. Accessed: 21 October 2008
• 25 Kantsevoy S V, Cruz-Correa M R, Vaughn C A. et al . Endoscopic cryotherapy for the treatment of bleeding mucosal vascular lesion of the GI tract: a pilot study.  Gastrointest Endosc. 2003;  57 403-406
• 26 Canto M I, Dunbar K B, Okolo P. et al . Low flow CO₂-cryotherapy for high risk Barrett’s esophagus (BE) patients with high grade dysplasia and early adenocarcinoma: a pilot trial of feasibility and safety [abstract].  Gastrointest Endosc. 2008;  67 AB179
• 27 Johnston M H. Cryotherapy and other newer techniques.  Gastroint Endosc Clin N Am. 2003;  13 491-501
• 28 Baust J G, Gage A A. The molecular basis of cryosurgery.  BJU Int. 2005;  95 1187-1191
• 29 Gage A A, Baust J. Mechanisms of tissue injury in cryosurgery.  Cryobiology. 1998;  37 171-186
• 30 Eastone J A, Horwhat J D, Haluska O. et al . Cryoablation of swine esophageal mucosa: a direct comparison to argon plasma coagulation (APC) and multipolar electrocoagulation (MPEC).  Gastrointest Endosc. 2001;  53 A3448
• 31 Johnston M H, Schoenfeld P, Mysore J, Dubois A. Endoscopic spray cryotherapy: a new techique for mucosal ablation in the esophagus.  Gastrointest Endosc. 1999;  50 86-92
• 32 Johnston M, Eastone J A, Horwhat J D. et al . Cryoablation of Barrett’s esophagus: a pilot study.  Gastrointest Endosc. 2005;  62 842-848
• 33 Dumot J A, Vargo J J, Zuccaro G, Rice T W. Preliminary results of cryotherapy ablation for esophageal high grade dysplasia (HGD) or intra-mucosal cancer (IMC) in high risk non-surgical patients.  Gastrointest Endosc. 2007;  65 AB110
• 34 Cash B D, Johnston L R, Johnston M H. Cryospray ablation (CSA) in the palliative treatment of squamous cell carcinoma of the esophagus.  World J Surg Oncol. 2007;  5 34
• 35 Greenwald B D, Cash B D. Cryotherapy ablation of early stage esophageal cancer.  Gastrointest Endosc. 2007;  65 AB276
• 36 Greenwald B D, Horwhat J D, Abrams J A. et al . Endoscopic cryotherapy ablation is safe and well-tolerated in Barrett’s esophagus, esophageal dysplasia, and esophageal cancer.  Gastrointest Endosc. 2008;  67 AB76
• 37 Gossner L, May A, Stolte M. et al . KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett’s esophagus.  Gastrointest Endosc. 1999;  49 8-12
• 38 Sharma P, Jaffe P E, Bhattacharyya A, Sampliner R E. Laser and multipolar electrocoagulation ablation of early Barrett’s adenocarcinoma: long-term follow up.  Gastrointest Endosc. 1999;  49 442-446
• 39 Lightdale C J, Heier S K, Marcon N E. et al . Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial.  Gastrointest Endosc. 1995;  42 507-512
• 40 Wang K K, Lutzke L, Borkenhagen L. et al . Photodynamic therapy for Barrett’s esophagus: does light still have a role?.  Endoscopy. 2008;  40 1021-1025
• 41 Michopoulos S, Tsibouris P, Bouzakis H. et al . Complete regression of Barrett’s esophagus with heat probe thermocoagulation: mid-term results.  Gastrointest Endosc. 1999;  50 165-172